Oruka Therapeutics, Inc.
|
Price
$92.70
|
Friday
+11.63%
|
30 Day
+48.84%
|
90 Day
+175.16%
|
1 Year
+537.55%
|
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001.
3 Reasons to Watch ORKA
- Analysts See Another 111% Upside From Here. After a 537% run over the past year, you might expect the bull case to be tapped out, but Wall Street disagrees. Analysts are projecting the stock could more than double again from Friday's close, which makes the Jefferies Global Healthcare Conference presentation coming up a meaningful moment to watch for any catalyst that moves the needle.
- A Fresh Buy Upgrade Hits Right After an 11% Session. ORKA got upgraded to Buy over the weekend, landing just after the stock closed Friday up nearly 12% in a single session. When an upgrade drops on top of that kind of momentum, the question for next week is whether institutional buyers use it as a green light to add size or whether the stock needs a breather first.
- Insider Selling Is the One Thing to Keep an Eye On. The Head of Finance unloaded more than 10,000 shares, and that is worth putting in context before you get too comfortable with the bullish setup. Insider sales do not always signal trouble, especially after a 175% three-month run where locking in gains makes sense, but it is a data point worth weighing against the analyst optimism when markets reopen Monday.
Most traders wreck their accounts the same way: They skip a step they already knew to take. So I put the 7 that matter most on one page. Run it before any options trade — about 30 seconds — and you'll catch the bad ones before they cost you. The Smart Trade Options Checklist. Normally $29.97. Free today.
Download your free copy of the Smart Trade Options Checklist nowTop Market Headlines
MoonFox Alternative Data Expands Offline Foot Traffic Coverage to Leading China and Global Stocks
SHENZHEN, China, July 17, 2026 (GLOBE NEWSWIRE) -- MoonFox Data, China's leading alternative data provider, is proud to announce a major expansion ...
Read The Full StoryLouis Navellier: "This Could Be Bigger Than Nvidia" (Ad)
Popular Fox News guest Louis Navellier sat down for a tell-all interview on Elon Musk's little-known AI project in Tennessee. He reveals why competitors are flying spy planes overhead… and details three little-known stocks (not Tesla) he believes will soar from this $7 trillion shift.
The Full Story here.
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the AlertsJoby, Archer, and EHang Are Down 40% to 60% in 2026. Are Air Taxi Stocks Damaged Beyond Repair?
The air-taxi trade has come undone this year, it seems.
Read The Full Story3 EV Stocks Worth the Risk to Buy in July
The EV trade is not for the faint of heart in July 2026, but three names offer a rare combination of catalysts, valuation asymmetry and macro tailw...
Read The Full StoryALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)
Weiss Ratings' research shows the first half of 2026 could be very tough for not all, but certain stocks... Specifically, a radical shift is about to hit the market … And it could send some of America's most popular stocks crashing down. We've identified five stocks you should absolutely avoid as this event plays out
Click here now — before it's too late.5 Top Stocks With Relative Price Strength to Buy Right Now
JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions and solid fundamentals amid market uncertainty.
Read The Full StorySPCX: Buy now or wait? (Ad)
It's the biggest IPO in history... Should you buy in now – or wait for a dip? According to my colleague Joel Litman, who called AMD before it rose as much as 7,100%... The best answer is: neither. The biggest opportunity to profit from SpaceX is NOT by touching the regular stock. While pundits argue whether SpaceX's stock price is "fair" or not... The biggest chance to profit is happening completely outside of SPCX itself. It's tied to a hidden project at SpaceX – which has nothing to do with space... but could soon be worth 100 times more than SpaceX's regular launch business. To learn more about the new SpaceX division already live right now across the American south...
Click here to see a much better way to potentially profit from the SPCX IPO – without touching the stock.📈 Also Trending
When a secretive project gets a name, it means we're closer to a breakthrough than most people think. Behind the razor wire of a hidden government lab in Tennessee, 40,000 scientists are finishing work on an AI computer 283 trillion times more powerful than today's data centers — spanning more than...
Click here to get the details, free.
For years, we've been told SpaceX is a rocket company. But according to new satellite images from 300 miles above the Earth's surface, there is something very strange going on at SpaceX right now that has nothing to do with space. It could soon replace our need for foreign oil forever and ignite a $...
Click here to learn more.
When Elon Musk ran a Twitter poll in 2021, Tesla lost $30 billion in a single day. When he changed the Twitter logo to Dogecoin, the coin surged 30% overnight. No one alive moves markets the way Elon does. Larry Benedict — the trader who delivered a 279% return on cash in 2025 — says Elon's next mov...
Click here to find out what it is before the "Final Phase" begins.